BAX logo
BAX
Baxter International

Aging Populations And Rising Chronic Disease Will Expand Care Access

Published
14 Apr 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$43.58
45.0% undervalued intrinsic discount
08 Aug
US$23.98
Loading
1Y
-30.5%
7D
5.0%

Author's Valuation

US$43.6

45.0% undervalued intrinsic discount

AnalystHighTarget Fair Value

Narrative
Updates4

Shared on07 May 25
Fair value Decreased 18%

Read more

Shared on30 Apr 25
Fair value Increased 0.057%

AnalystHighTarget made no meaningful changes to valuation assumptions.

Read more

Shared on23 Apr 25
Fair value Increased 14%

AnalystHighTarget has increased future PE multiple from 30.4x to 34.7x.

Read more

Shared on16 Apr 25
Fair value Decreased 11%

AnalystHighTarget made no meaningful changes to valuation assumptions.

Read more